Sign In
Buy FREQ
$0.300
+0 (+0%)
At Close: Feb 02, 2024
Frequency Therapeutics, Inc. (FREQ) Reports Q3 Loss, Lags Revenue Estimates
05:25pm, Monday, 15'th Nov 2021 Zacks Investment Research
Frequency Therapeutics, Inc. (FREQ) delivered earnings and revenue surprises of -32.73% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead f
Frequency Therapeutics, Inc. (FREQ) Reports Q3 Loss, Lags Revenue Estimates
01:55pm, Monday, 15'th Nov 2021
Frequency Therapeutics, Inc. (FREQ) delivered earnings and revenue surprises of -32.73% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead f
Frequency Therapeutics, Inc. (NASDAQ:FREQ) Forecasted to Post Q3 2021 Earnings of ($0.22) Per Share
06:08am, Monday, 15'th Nov 2021 Transcript Daily
Frequency Therapeutics, Inc. (NASDAQ:FREQ) B. Riley raised their Q3 2021 earnings per share (EPS) estimates for Frequency Therapeutics in a report issued on Wednesday, November 10th. B. Riley analyst M. Mamtani now expects that the company will post earnings of ($0.22) per share for the quarter, up from their previous estimate of ($0.83). B. []
Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs
10:19am, Tuesday, 09'th Nov 2021
In Frequency Therapeutics' short lifetime as a company, it's had its ups and downs. On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the developme
Analysts Estimate Frequency Therapeutics, Inc. (FREQ) to Report a Decline in Earnings: What to Look Out for
04:06pm, Monday, 08'th Nov 2021
Frequency Therapeutics, Inc. (FREQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Frequency Therapeutics' New Data Of Hearing Loss Candidate Fails To Impress Investors
11:18am, Wednesday, 22'nd Sep 2021
Frequency Therapeutics Inc (NASDAQ: FREQ) has announced that four additional sensorineural hearing loss (SNHL) subjects from its FX-322-111 open-label study achieved statistically significant hearin
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate regenera
Frequency Therapeutics to Present at Upcoming Investor Conferences
07:30am, Wednesday, 08'th Sep 2021
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage cause
Moore Kuehn, PLLC Encourages Investors of FREQ to Contact Law Firm
04:06pm, Thursday, 12'th Aug 2021
New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding
Frequency Therapeutics Provides Business Updates and Second Quarter 2021 Financial Results
07:30am, Thursday, 12'th Aug 2021
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage cause
Analysts Estimate Frequency Therapeutics, Inc. (FREQ) to Report a Decline in Earnings: What to Look Out for
04:48pm, Wednesday, 04'th Aug 2021
Frequency Therapeutics, Inc. (FREQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New York, New York--(Newsfile Corp. - August 2, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) be
Los Angeles, California--(Newsfile Corp. - August 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Frequency Therape
New York, New York--(Newsfile Corp. - August 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Frequency Therapeutics, Inc. (NASDAQ: FREQ) betw
